Literature DB >> 8286640

Human intestinal capillariasis in an area of nonendemicity: case report and review.

F Dronda1, F Chaves, A Sanz, R Lopez-Velez.   

Abstract

We report a rare case of human intestinal capillariasis in a young Colombian man who presented with abdominal pain and mild, self-limited diarrhea. Capillaria eggs were visualized in the feces, and treatment with mebendazole (200 mg/d for 3 weeks) resulted in clinical and parasitological cure. To our knowledge, this is the first case in a South American person and the second case reported in Europe. This case highlights the acquisition of endemic intestinal parasitosis far away from classically considered areas of endemicity. We review the English-language literature on human intestinal capillariasis and compare findings from other cases with those from the current case.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8286640     DOI: 10.1093/clinids/17.5.909

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

1.  An indigenous case of intestinal capillariasis with protein-losing enteropathy in Korea.

Authors:  Woon Tae Jung; Hyun Jin Kim; Hyun Ju Min; Chang Yoon Ha; Hong Jun Kim; Gyung Hyuck Ko; Byoung-Kuk Na; Woon-Mok Sohn
Journal:  Korean J Parasitol       Date:  2012-11-26       Impact factor: 1.341

2.  A Hospital-Based Study of Intestinal Capillariasis in Thailand: Clinical Features, Potential Clues for Diagnosis, and Epidemiological Characteristics of 85 Patients.

Authors:  Lakkhana Sadaow; Oranuch Sanpool; Pewpan M Intapan; Wattana Sukeepaisarnjaroen; Thidarat K Prasongdee; Wanchai Maleewong
Journal:  Am J Trop Med Hyg       Date:  2018-01-01       Impact factor: 2.345

3.  Potential use of Trichinella spiralis antigen for serodiagnosis of human capillariasis philippinensis by immunoblot analysis.

Authors:  Pewpan M Intapan; Wanchai Maleewong; Wattana Sukeepaisarnjaroen; Nimit Morakote
Journal:  Parasitol Res       Date:  2005-12-07       Impact factor: 2.289

Review 4.  Anthelmintics. A comparative review of their clinical pharmacology.

Authors:  N de Silva; H Guyatt; D Bundy
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

5.  High Prevalence of Intestinal Capillariasis in Chronic Diarrhea Patients in Thailand: Serological Screening Using a Rapid Lateral-Flow Immunochromatographic Assay.

Authors:  Thidarat K Prasongdee; Krongkaew Seesui; Phuangphaka Sadee; Lakkhana Sadaow; Wattana Sukeepaisarnjaroen; Ratthaphol Kraiklang; Oranuch Sanpool; Wanchai Maleewong; Pewpan M Intapan
Journal:  Am J Trop Med Hyg       Date:  2022-07-05       Impact factor: 3.707

6.  Clinical features of human intestinal capillariasis in Taiwan.

Authors:  Ming-Jong Bair; Kao-Pin Hwang; Tsang-En Wang; Tai-Cherng Liou; Shee-Chan Lin; Chin-Roa Kao; Tao-Yeuan Wang; Kwok-Kuen Pang
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

7.  Intestinal capillariasis diagnosed by endoscopic biopsy.

Authors:  Minsu Ha; Dong-Ha Jun; Jung Ho Kim; Yoon Jae Kim; Kwang An Kwon; Dong Kyun Park; Yang Suh Ku
Journal:  Clin Endosc       Date:  2013-11-19

Review 8.  An Overview of Fish-borne Nematodiases among Returned Travelers for Recent 25 Years- Unexpected Diseases Sometimes Far Away from the Origin.

Authors:  Jorge Costa Eiras; Gilberto Cezar Pavanelli; Ricardo Massato Takemoto; Yukifumi Nawa
Journal:  Korean J Parasitol       Date:  2018-06-30       Impact factor: 1.341

9.  Epidemiology of Strongyloides stercoralis in northern Italy: results of a multicentre case-control study, February 2013 to July 2014.

Authors:  Dora Buonfrate; Mara Baldissera; Fabrizio Abrescia; Matteo Bassetti; Giacomo Caramaschi; Mario Giobbia; Marta Mascarello; Paola Rodari; Novella Scattolo; Giuseppina Napoletano; Zeno Bisoffi
Journal:  Euro Surveill       Date:  2016-08-04

10.  Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update.

Authors:  Jong-Yil Chai; Bong-Kwang Jung; Sung-Jong Hong
Journal:  Korean J Parasitol       Date:  2021-06-21       Impact factor: 1.341

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.